Blood

High-cost blood cancer drugs deliver high value

Amid the growing debate about the high price of powerful new drugs in the United States, a recent analysis suggests that breakthrough therapies for blood cancers may, in many cases and with some important caveats, provide ...

Feb 05, 2015
popularity 7 comments 0

Inhibiting CDK6 prevents leukemic relapse

Despite enormous progress in cancer therapy, many patients still relapse because their treatment addresses the symptoms of the disease rather than the cause, the so-called stem cells. Work in the group of ...

Jan 27, 2015
popularity 6 comments 0